Avonex intramuscular injection syringe 30 μg

Avonex intramuscular injection syringe 30 μg, manufactured by Biogen Japan, contains Interferon beta-1a (genetically recombinant). This injectable drug (YJ code: 6399422G1027) is supplied as 30μg in 0.5mL per tube and is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations.